Hospital discharges for hyperplasia of prostate in South Korea have shown fluctuations between 2013 and 2023. In 2023, the discharges stood at 21.9 thousand, representing a 5.71% year-on-year increase from 2022. The past decade reflects a series of ups and downs with notable declines, such as a 14.34% drop in 2020 likely due to the COVID-19 pandemic, contrasted by robust recovery patterns visible from 2021 onwards. The 5-year CAGR leading to 2023 was 1.72%, indicating modest growth. From 2024 onward, the discharges are forecasted to continue increasing, with a projected 5-year CAGR of 1.89%, culminating in a growth rate of 9.82% by 2028.
Going forward, key trends to monitor include the impact of demographic changes, such as aging population, advancements in treatment options, and healthcare policy reforms. Staying ahead of these factors will be crucial for anticipating future hospital discharge needs.
